APA (7th ed.) Citation

SM, L., SD, Y., S, L., SG, H., S, D., A, M., . . . BC, C. (2022). Molecular landscape of osimertinib resistance in patients and patient-derived preclinical models. Therapeutic advances in medical oncology, 14, 17588359221079125. https://doi.org/10.1177/17588359221079125

Chicago Style (17th ed.) Citation

SM, Lim, et al. "Molecular Landscape of Osimertinib Resistance in Patients and Patient-derived Preclinical Models." Therapeutic Advances in Medical Oncology 14 (2022): 17588359221079125. https://doi.org/10.1177/17588359221079125.

MLA (9th ed.) Citation

SM, Lim, et al. "Molecular Landscape of Osimertinib Resistance in Patients and Patient-derived Preclinical Models." Therapeutic Advances in Medical Oncology, vol. 14, 2022, p. 17588359221079125, https://doi.org/10.1177/17588359221079125.